Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
Open accessThe DOI matches its Crossref record; 202 of the 202 references it cites were found in a registry or an index.
Abstract
Hepatitis C (HCV) is a major cause of liver disease, in which a third of individuals with chronic HCV infections may develop liver cirrhosis. In a chronic HCV infection, host immune factors along with the actions of HCV proteins that promote viral persistence and dysregulation of the immune system have an impact on immunopathogenesis of HCV-induced hepatitis. The genome of HCV encodes a single polyprotein, which is translated and processed into structural and nonstructural proteins. These HCV proteins are the target of the innate and adaptive immune system of the host. Retinoic acid-inducible gene-I (RIG-I)-like receptors and Toll-like receptors are the main pattern recognition receptors that recognize HCV pathogen-associated molecular patterns. This interaction results in a downstream cascade that generates antiviral cytokines including interferons. The cytolysis of HCV-infected hepatocytes is mediated by perforin and granzyme B secreted by cytotoxic T lymphocyte (CTL) and natural killer (NK) cells, whereas noncytolytic HCV clearance is mediated by interferon gamma (IFN-γ) secreted by CTL and NK cells. A host–HCV interaction determines whether the acute phase of an HCV infection will undergo complete resolution or progress to the development of viral persistence with a consequential progression to chronic HCV infection. Furthermore, these host–HCV interactions could pose a challenge to developing an HCV vaccine. This review will focus on the role of the innate and adaptive immunity in HCV infection, the failure of the immune response to clear an HCV infection, and the factors that promote viral persistence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753 · cited 1×
“MDSCs suppress the effector function of target cells through multiple mechanisms (reviewed in detail in References [107,108]).”
BackgroundInterleukin-10 and the Interleukin-10 Receptor
Moore, K. W., de Waal Malefyt, R., Coffman, R. L., & O'Garra, A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.683 · Cited by 6,737
Protective and pathogenic functions of macrophage subsets
Murray, P. J., & Wynn, T. A. (2011) · Nature Reviews Immunology · doi:10.1038/nri3073 · Cited by 5,269 · cited 1×
“Inside the tissues, macrophages perform several important functions such as a regulation of tissue homeostasis, immune surveillance, and inflammation [99,100].”
BackgroundThe HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089 · cited 1×
“MDSCs are viewed as distinct from terminally differentiated myeloid cells such as macrophages and DCs; however, it is important to recognize that macrophages can also exhibit T-cell-suppressive activity [105,106].”
BackgroundRestoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840 · cited 1×
“MDSCs are viewed as distinct from terminally differentiated myeloid cells such as macrophages and DCs; however, it is important to recognize that macrophages can also exhibit T-cell-suppressive activity [105,106].”
BackgroundCardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
Merad, M., Sathe, P., Helft, J., Miller, J., & Mortha, A. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-074950 · Cited by 2,309 · cited 1×
“Classic DCs (cDCs) form the predominant DC subset and their main function is to sample antigens in tissues and migrate to local draining lymph nodes to induce antigen-specific T cell immunity or tolerance [101,102].”
BackgroundGenetic variation in IL28B and spontaneous clearance of hepatitis C virus
Thomas, D. L., Thio, C. L., Martin, M. P., Qi, Y., Ge, D., O’hUigin, C., Kidd, J., Kidd, K., Khakoo, S. I., Alexander, G., et al. (2009) · Nature · doi:10.1038/nature08463 · Cited by 2,150 · cited 1×
“Genomic wide studies have shown that rs12979860 [28] and rs8099917 [29] are associated with a spontaneous resolution of an HCV infection.”
BackgroundHepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
Neumann, A. U., Lam, N. P., Dahari, H., Gretch, D. R., Wiley, T. E., Layden, T. J., & Perelson, A. S. (1998) · Science · doi:10.1126/science.282.5386.103 · Cited by 2,113
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Davies, L. C., Jenkins, S. J., Allen, J. E., & Taylor, P. R. (2013) · Nature Immunology · doi:10.1038/ni.2705 · Cited by 2,096 · cited 1×
“Inside the tissues, macrophages perform several important functions such as a regulation of tissue homeostasis, immune surveillance, and inflammation [99,100].”
BackgroundBlackburn, S. D., Shin, H., Haining, W. N., Zou, T., Workman, C. J., Polley, A., Betts, M. R., Freeman, G. J., Vignali, D. A. A., & Wherry, E. J. (2009) · Nature Immunology · doi:10.1038/ni.1679 · Cited by 2,062 · cited 1×
“The co-expression of multiple distinct inhibitory receptors was found to determine the level of CD8+ T cell exhaustion as well as the severity of infection [192].”
BackgroundViral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Myeloid-Derived Suppressor Cells
Gabrilovich, D. I. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0297 · Cited by 1,882 · cited 1×
“MDSCs suppress the effector function of target cells through multiple mechanisms (reviewed in detail in References [107,108]).”
BackgroundMyeloid-derived suppressor cells coming of age
Veglia, F., Perego, M., & Gabrilovich, D. (2018) · Nature Immunology · doi:10.1038/s41590-017-0022-x · Cited by 1,767 · cited 1×
“MDSCs are a heterogeneous population of cells that are defined by their myeloid origin, immature state, and ability to potently suppress T cell responses [104].”
BackgroundWherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most, R., & Ahmed, R. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4911-4927.2003 · Cited by 1,610
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.11.006 · Cited by 1,354
Decisions About Dendritic Cells: Past, Present, and Future
Steinman, R. M. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-100311-102839 · Cited by 1,274 · cited 1×
“Classic DCs (cDCs) form the predominant DC subset and their main function is to sample antigens in tissues and migrate to local draining lymph nodes to induce antigen-specific T cell immunity or tolerance [101,102].”
BackgroundAnalysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269 · cited 1×
“and IL-2, which enhance the antigen presenting capabilities of DC and the proliferation of HCV-specific CD8+ T cells respectively [45,67].”
BackgroundType I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,195 · cited 1×
“Type I (IFN-α and IFN-β) and type III (IFN-λ) interferon via their respective receptors phosphorylate STAT-1 and STAT-2 to generate IFN-stimulated gene factor 3 (ISGF3), a transcription factor that translocate into the nucleus, where they play a role in producing IFN-stimulated antiviral genes [31,49].”
BackgroundDeterminants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection
Thimme, R., Oldach, D., Chang, K.-M., Steiger, C., Ray, S. C., & Chisari, F. V. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.10.1395 · Cited by 1,189 · cited 2×
“During an acute infection with HCV, viral RNA is detected in the blood within 1–2 weeks postinfection [44] and activates the innate and adaptive arms of the immune response.”
BackgroundHLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection
Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., et al. (2004) · Science · doi:10.1126/science.1097670 · Cited by 1,179 · cited 1×
“An upregulation of KIR receptors which are found on NK cells and are markers for lysis of the target cells is seen during an HCV infection, indicating the importance of NK cells [54].”
BackgroundRauch, A., Kutalik, Z., Descombes, P., Cai, T., Di Iulio, J., Mueller, T., Bochud, M., Battegay, M., Bernasconi, E., Borovicka, J., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.056 · Cited by 1,137 · cited 1×
“Genomic wide studies have shown that rs12979860 [28] and rs8099917 [29] are associated with a spontaneous resolution of an HCV infection.”
BackgroundThe multifaceted biology of plasmacytoid dendritic cells
Swiecki, M., & Colonna, M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3865 · Cited by 1,131 · cited 1×
“Plasmacytoid DCs (pDCs) are another DC subset that produce high levels of interferon-α (IFN-α) after sensing an infection [103].”
BackgroundLi, K., Foy, E., Ferreon, J. C., Nakamura, M., Ferreon, A. C. M., Ikeda, M., Ray, S. C., Gale, M., & Lemon, S. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408824102 · Cited by 1,092 · cited 1×
“It is of note that HCV NS3/4A protease interferes with RIG-I and TLR3 signaling by cleaving MAVS and TRIF, two human proteins known to play a critical role in innate immune response [144,145].”
BackgroundDendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity
Liu, Y.-J. (2001) · Cell · doi:10.1016/s0092-8674(01)00456-1 · Cited by 1,004
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Wynn, T. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141142 · Cited by 958
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923 · cited 1×
“This impairment of T cell function, particularly that of CD4+ and CD8+ T cells, by an increased expression of IL-10 has also been supported by studies involving the LCMV model [204,205].”
ResultThe Natural History of Hepatitis C Virus (HCV) Infection
Chen, S. L., & Morgan, T. R. (2006) · International Journal of Medical Sciences · doi:10.7150/ijms.3.47 · Cited by 860 · cited 4×
“MDSCs suppress the effector function of target cells through multiple mechanisms (reviewed in detail in References [107,108]).”
BackgroundInfluentialLi, X.-D., Sun, L., Seth, R. B., Pineda, G., & Chen, Z. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508531102 · Cited by 840 · cited 1×
“It is of note that HCV NS3/4A protease interferes with RIG-I and TLR3 signaling by cleaving MAVS and TRIF, two human proteins known to play a critical role in innate immune response [144,145].”
BackgroundGenetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes
Bukh, J., Miller, R., & Purcell, R. (1995) · Seminars in Liver Disease · doi:10.1055/s-2007-1007262 · Cited by 833
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B
Sorrell, M. F., Belongia, E. A., Costa, J., Gareen, I. F., Grem, J. L., Inadomi, J. M., Kern, E. R., McHugh, J. A., Petersen, G. M., Rein, M. F., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00100 · Cited by 832
HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help
Grakoui, A., Shoukry, N. H., Woollard, D. J., Han, J.-H., Hanson, H. L., Ghrayeb, J., Murthy, K. K., Rice, C. M., & Walker, C. M. (2003) · Science · doi:10.1126/science.1088774 · Cited by 830 · cited 1×
“It has been shown that HCV infection does not result in the development of sterilizing immunity but rather the memory CD4+ and CD8+ T cells provide protective immunity with CD4+ T cells providing help to CD8+ T cell to respond to viral escape mutants in class I MHC-restricted epitopes [84,85].”
BackgroundUnravelling hepatitis C virus replication from genome to function
Lindenbach, B. D., & Rice, C. M. (2005) · Nature · doi:10.1038/nature04077 · Cited by 820 · cited 1×
“5-kb genomes encoding a single open reading frame (ORF) that, when translated, results in the production of an approximately 3000-amino-acid-long polyprotein [12].”
BackgroundInnate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J., & Gale, M. (2008) · Nature · doi:10.1038/nature07106 · Cited by 744 · cited 1×
“An interaction between the HCV dsRNA replication intermediate and ssRNA with RIG-I and melanoma differentiation-associated gene 5 (MDA-5) activate the Toll/IL-1R- (TIR) containing adapter inducing IFN-β (TRIF) and mitochondria antiviral signaling protein (MAVS), which phosphorylate IFN regulatory factor 3 (IRF3) and I…”
BackgroundTakaki, A., Wiese, M., Maertens, G., Depla, E., Seifert, U., Liebetrau, A., Miller, J. L., Manns, M. P., & Rehermann, B. (2000) · Nature Medicine · doi:10.1038/75063 · Cited by 739
The PD-1–PD-L pathway in immunological tolerance
Okazaki, T., & Honjo, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.02.001 · Cited by 721 · cited 1×
“PD-1 interacts with its ligands PD-L1 (or B7-H1) and PD-L2 (B7-DC) to regulate immune responses in both lymphoid and nonlymphoid organs [193].”
BackgroundGerlach, J. T., Diepolder, H. M., Jung, M., Gruener, N. H., Schraut, W. W., Zachoval, R., Hoffmann, R., Schirren, C. A., Santantonio, T., & Pape, G. R. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70353-7 · Cited by 714
Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G., Bonino, F., Crawford, K., Marion, C. D., & Crawford, K. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.8.3468 · Cited by 704 · cited 1×
“Likewise, the hypervariable region 1 (HVR 1), a small fragment spanning 27 amino acids of E2 on a highly variable region of HCV genome, is a sequence mutation that plays a role in evading neutralization by HCV-specific antibodies [45,135,136].”
BackgroundCharacterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690 · cited 1×
“occurring in the hypervariable region 1 of E2 along with the potential of HVR 1 to interfere with the binding of antibodies to E2 [233], (4) the cell to cell transmission of HCV constituting a considerable hindrance to developing B-cell-based HCV vaccines that induce broad cross-neutralizing antibodies since HCV could…”
BackgroundStructural biology of hepatitis C virus
Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D., & Pawlotsky, J.-M. (2004) · Hepatology · doi:10.1002/hep.20032 · Cited by 683 · cited 2×
“NS5B is another important enzyme involved in viral transcription and replication, as well as an RNA-dependent RNA polymerase of HCV [15].”
BackgroundMemory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
Shoukry, N. H., Grakoui, A., Houghton, M., Chien, D. Y., Ghrayeb, J., Reimann, K. A., & Walker, C. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030239 · Cited by 656 · cited 1×
“It has been shown that HCV infection does not result in the development of sterilizing immunity but rather the memory CD4+ and CD8+ T cells provide protective immunity with CD4+ T cells providing help to CD8+ T cell to respond to viral escape mutants in class I MHC-restricted epitopes [84,85].”
BackgroundViral and immunological determinants of hepatitis C virus clearance, persistence, and disease
Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H., & Chisari, F. V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608299 · Cited by 639
Wedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., & Rehermann, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3447 · Cited by 634
Vital Involvement of a Natural Killer Cell Activation Receptor in Resistance to Viral Infection
Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R. C., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E., Stone, L. R., Scalzo, A. A., & Yokoyama, W. M. (2001) · Science · doi:10.1126/science.1060042 · Cited by 627
TH1 cells control themselves by producing interleukin-10
O'Garra, A., & Vieira, P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2097 · Cited by 617
Urbani, S., Amadei, B., Tola, D., Massari, M., Schivazappa, S., Missale, G., & Ferrari, C. (2006) · Journal of Virology · doi:10.1128/jvi.01177-06 · Cited by 588 · cited 1×
“Additionally, high PD-1 levels on HCV specific T cells during an acute infection may determine the viral persistence and progression to a chronic infection [194,197].”
BackgroundAn immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection
Cabrera, R., Tu, Z., Xu, Y., Firpi, R. J., Rosen, H. R., Liu, C., & Nelson, D. R. (2004) · Hepatology · doi:10.1002/hep.20454 · Cited by 562 · cited 1×
“In patients with chronic hepatitis C, the frequency of CD4+CD25+ T cells (TR cells) is reported to be high [207], and these cells can suppress virus-specific CD8+ T cells via the action of immunosuppressive cytokines they secrete.”
BackgroundHuman intracellular ISG15 prevents interferon-α/β over-amplification and auto-inflammation
Zhang, X., Bogunovic, D., Payelle-Brogard, B., Francois-Newton, V., Speer, S. D., Yuan, C., Volpi, S., Li, Z., Sanal, O., Mansouri, D., et al. (2015) · Nature · doi:10.1038/nature13801 · Cited by 558
Side effects of therapy of hepatitis C and their management
Fried, M. W. (2002) · Hepatology · doi:10.1002/hep.1840360730 · Cited by 556 · cited 1×
“However, patients undergoing interferon-based treatment often experienced adverse side effects, including fatigue, headache, pyrexia, myalgia, insomnia, alopecia, arthralgia, anorexia, tinnitus, and depression [213].”
BackgroundUnderstanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554 · cited 1×
“The NS5B and helicase domain of NS3 are regulators of HCV replication, which helps to unwind and stabilize the HCV RNA in a replication complex [41,42].”
BackgroundResolution of a chronic viral infection after interleukin-10 receptor blockade
Ejrnaes, M., Filippi, C. M., Martinic, M. M., Ling, E. M., Togher, L. M., Crotty, S., & von Herrath, M. G. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061462 · Cited by 548 · cited 1×
“This impairment of T cell function, particularly that of CD4+ and CD8+ T cells, by an increased expression of IL-10 has also been supported by studies involving the LCMV model [204,205].”
ResultFoy, E., Li, K., Sumpter, R., Loo, Y.-M., Johnson, C. L., Wang, C., Fish, P. M., Yoneyama, M., Fujita, T., Lemon, S. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408707102 · Cited by 548 · cited 1×
“An interaction between the HCV dsRNA replication intermediate and ssRNA with RIG-I and melanoma differentiation-associated gene 5 (MDA-5) activate the Toll/IL-1R- (TIR) containing adapter inducing IFN-β (TRIF) and mitochondria antiviral signaling protein (MAVS), which phosphorylate IFN regulatory factor 3 (IRF3) and I…”
BackgroundManns, M. P., Buti, M., Gane, E., Pawlotsky, J.-M., Razavi, H., Terrault, N., & Younossi, Z. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.6 · Cited by 506 · cited 10×
“4 to increase the efficiency f translation and Cyclop ilin A, which interacts with NS5A and NS5B to increase HCV replication [14].”
BackgroundInfluentialAntigen-independent memory CD8 T cells do not develop during chronic viral infection
Wherry, E. J., Barber, D. L., Kaech, S. M., Blattman, J. N., & Ahmed, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407192101 · Cited by 497 · cited 1×
“Another phenotypic feature of exhausted CD8+ T cells when compared with memory CD8+ T cells is the lowered expression of IL-7Rα (CD127) and IL-2Rβ (CD122), the receptors for the homeostatic cytokines IL-7 and IL-15, respectively [198,199].”
BackgroundSustained Dysfunction of Antiviral CD8+T Lymphocytes after Infection with Hepatitis C Virus
Gruener, N. H., Lechner, F., Jung, M.-C., Diepolder, H., Gerlach, T., Lauer, G., Walker, B., Sullivan, J., Phillips, R., Pape, G. R., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5550-5558.2001 · Cited by 495
Radziewicz, H., Ibegbu, C. C., Fernandez, M. L., Workowski, K. A., Obideen, K., Wehbi, M., Hanson, H. L., Steinberg, J. P., Masopust, D., Wherry, E. J., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02021-06 · Cited by 483 · cited 5×
“Although the expression of coinhibitory molecules on activated T cells is protective, an overexpression of coinhibitory receptors in the setting of a low expression of CD127 on HCV-specific CD4+ T cells is associated with a persistent HCV infection, in which, the loss of CD4+ T cell negatively impact on the functional…”
BackgroundInfluentialWoodchuck hepatitis virus X protein is required for viral infection in vivo
Zoulim, F., Saputelli, J., & Seeger, C. (1994) · Journal of Virology · doi:10.1128/jvi.68.3.2026-2030.1994 · Cited by 453 · cited 1×
“These two glycoproteins interact with CD81 and various other surface proteins such as claudin-1 [1,37,38], occludin, and epidermal growth factor receptor to access the cell [39].”
BackgroundBinding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions
Tseng, C.-T. K., & Klimpel, G. R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011145 · Cited by 447 · cited 1×
“The binding of HCV E2 proteins to CD81 on NK cells was shown to be associated with an impaired NK cell-mediated cytolytic function and an impaired IFN-γ production [158].”
BackgroundDNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
Bigger, C. B., Brasky, K. M., & Lanford, R. E. (2001) · Journal of Virology · doi:10.1128/jvi.75.15.7059-7066.2001 · Cited by 442 · cited 1×
“The innate immune response includes type I interferon in infected cells [45], which induces double-stranded RNA-dependent protein kinase (PKR) and other genes to induce apoptosis of infected hepatocytes, as well as to inhibit viral replication [46].”
BackgroundNeutralizing antibody response during acute and chronic hepatitis C virus infection
Logvinoff, C., Major, M. E., Oldach, D., Heyward, S., Talal, A., Balfe, P., Feinstone, S. M., Alter, H., Rice, C. M., & McKeating, J. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403519101 · Cited by 433 · cited 1×
“Neutralizing antibodies are thought to have a lesser role in controlling an HCV infection as they were detected more in chronic stages rather than after acute infections [74].”
BackgroundNegash, A. A., Ramos, H. J., Crochet, N., Lau, D. T. Y., Doehle, B., Papic, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003330 · Cited by 414 · cited 1×
“IL-1β induces the chronic activation of innate immune-mediated inflammation [215,216].”
BackgroundInnate and adaptive lymphoid cells in the human liver
Doherty, D. G., & O'Farrelly, C. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017416.x · Cited by 402 · cited 1×
“Natural killer T (NKT) cells are another group of innate cells, which comprise 26% of intrahepatic lymphocytes [59,60] and secrete IFN-γ, TNFα, and IL-2 [60].”
BackgroundTimpe, J. M., Stamataki, Z., Jennings, A., Hu, K., Farquhar, M. J., Harris, H. J., Schwarz, A., Desombere, I., Roels, G. L., Balfe, P., et al. (2008) · Hepatology · doi:10.1002/hep.21959 · Cited by 389 · cited 2×
“Due to a direct cell to cell transmission of HCV, it often escapes the antibodies and is difficult to neutralize [70].”
BackgroundDC-SIGN and L-SIGN Are High Affinity Binding Receptors for Hepatitis C Virus Glycoprotein E2
Lozach, P.-Y., Lortat-Jacob, H., De Lacroix De Lavalette, A., Staropoli, I., Foung, S., Amara, A., Houlès, C., Fieschi, F., Schwartz, O., Virelizier, J.-L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301284200 · Cited by 375 · cited 1×
“Consistent with this, the HCV pseudo virus was shown to bind DC-SIGN expressed on monocyte-derived DCs and was transmitted efficiently when cocultured with the human hepatocellular carcinoma cell line Huh7, a cell line that supports HCV pseudovirus entry and productive infection [116,117].”
BackgroundBengsch, B., Seigel, B., Ruhl, M., Timm, J., Kuntz, M., Blum, H. E., Pircher, H., & Thimme, R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000947 · Cited by 373
Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F. A., Alter, H. J., & Chang, K.-M. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.026 · Cited by 369 · cited 1×
“Depletion of CD4+CD25+ Treg cells from peripheral blood resulted in the recovery of proliferation and peptide-specific IFN-γ production by HCV-specific CD8+ T cells [208].”
BackgroundSwadling, L., Capone, S., Antrobus, R. D., Brown, A., Richardson, R., Newell, E. W., Halliday, J., Kelly, C., Bowen, D., Fergusson, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009185 · Cited by 343 · cited 1×
“[231] demonstrated that a human prophylactic T-cell-based HCV vaccine induced the production of both CD4+ and CD8+ T cells.”
BackgroundKittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J., & Hahn, Y. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10323 · Cited by 333 · cited 1×
“Likewise, the HCV core protein interacts with gC1qR on monocyte-derived DC to reduce IL-2 expression, consequentially inhibiting T cell proliferation [154].”
BackgroundBode, J. G., Ludwig, S., Ehrhardt, C., Erhardt, A., Albrecht, U., Schaper, F., Heinrich, P. C., & Häussinger, D. (2003) · The FASEB Journal · doi:10.1096/fj.02-0664fje · Cited by 312 · cited 8×
“It is important to note that, during HCV infection, the levels of IFNs and ISGs are always upregulated in the cell.”
BackgroundInfluentialLechner, F., Gruener, N. H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A. R., Cerny, A., Phillips, R., Ferrari, C., Pape, G. R., et al. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200009)30:9<2479::aid-immu2479>3.0.co;2-b · Cited by 312 · cited 1×
“A sustained vigorous HCV-specific CTL response is associated with the resolution of an acute HCV infection; however, suboptimal performing CTL correlates with viral persistence [81,82].”
BackgroundAuffermann-Gretzinger, S., Keeffe, E. B., & Levy, S. (2001) · Blood · doi:10.1182/blood.v97.10.3171 · Cited by 304 · cited 2×
“Furthermore, studies have shown that mDCs in the setting of an HCV infection have reduced the expression of costimulatory molecules (CD83 and CD86) and impaired the ability to secrete IL-12, which results in an impaired ability of mDC to present antigen to T cells [176,177].”
BackgroundAccapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L. V., Cividini, A., Abrignani, S., Mondelli, M. U., & Barnaba, V. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420515 · Cited by 303
Hepatitis C Virus Proteins: From Structure to Function
Moradpour, D., & Penin, F. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-27340-7_5 · Cited by 301 · cited 1×
“HCV translates a large polyprotein which is broken down by cellular (Signalase and Signal peptide peptidase) and viral (NS2 and NS3/4A) proteases into structural and nonstructural proteins during ER-related processing [40].”
BackgroundInfluence of MHC class II genotype on outcome of infection with hepatitis C virus
Thursz, M., Yallop, R., Goldin, R., Trepo, C., & Thomas, H. C. (1999) · The Lancet · doi:10.1016/s0140-6736(99)91443-5 · Cited by 287 · cited 1×
“HLA-DRB1*0101 [89,90], HLA DRB1 *0501 [91], and HLA DQB1*0301 [89,92,93] are associated with the spontaneous clearance of HCV.”
BackgroundPenna, A., Pilli, M., Zerbini, A., Orlandini, A., Mezzadri, S., Sacchelli, L., Missale, G., & Ferrari, C. (2007) · Hepatology · doi:10.1002/hep.21541 · Cited by 285
Interleukin-1 participates in the progression from liver injury to fibrosis
Gieling, R. G., Wallace, K., & Han, Y.-P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90564.2008 · Cited by 281 · cited 1×
“IL-1β induces the chronic activation of innate immune-mediated inflammation [215,216].”
BackgroundFunctional signatures of protective antiviral T‐cell immunity in human virus infections
Harari, A., Dutoit, V., Cellerai, C., Bart, P., Du Pasquier, R. A., & Pantaleo, G. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00395.x · Cited by 273 · cited 1×
“In recent years, a greater emphasis has been put on the need for a polyfunctional population of T cells, which can be correlated to a better control of viral load [181].”
BackgroundOsburn, W. O., Snider, A. E., Wells, B. L., Latanich, R., Bailey, J. R., Thomas, D. L., Cox, A. L., & Ray, S. C. (2014) · Hepatology · doi:10.1002/hep.27013 · Cited by 272 · cited 1×
“The development of a robust early humoral immune response via neutralizing antibodies in the initial phase of an HCV infection is likely to result in the spontaneous clearance of a viral infection [224,225].”
BackgroundJinushi, M., Takehara, T., Kanto, T., Tatsumi, T., Groh, V., Spies, T., Miyagi, T., Suzuki, T., Sasaki, Y., & Hayashi, N. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1249 · Cited by 260
Paul, D., Hoppe, S., Saher, G., Krijnse-Locker, J., & Bartenschlager, R. (2013) · Journal of Virology · doi:10.1128/jvi.01370-13 · Cited by 259 · cited 1×
“NS3, NS4A, NS4B, NS5A, and NS5B forms the replicase machinery and NS2 and p7 are essential for viral assembly and release [22].”
BackgroundNeutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
Brimacombe, C. L., Grove, J., Meredith, L. W., Hu, K., Syder, A. J., Flores, M. V., Timpe, J. M., Krieger, S. E., Baumert, T. F., Tellinghuisen, T. L., et al. (2011) · Journal of Virology · doi:10.1128/jvi.01592-10 · Cited by 256 · cited 1×
“occurring in the hypervariable region 1 of E2 along with the potential of HVR 1 to interfere with the binding of antibodies to E2 [233], (4) the cell to cell transmission of HCV constituting a considerable hindrance to developing B-cell-based HCV vaccines that induce broad cross-neutralizing antibodies since HCV could…”
BackgroundMcKiernan, S. M., Hagan, R., Curry, M., McDonald, G. S. A., Kelly, A., Nolan, N., Walsh, A., Hegarty, J., Lawlor, E., & Kelleher, D. (2004) · Hepatology · doi:10.1002/hep.20261 · Cited by 255 · cited 2×
“However, HLA B08 [95] and HLA Cw*04 [96] are associated with a persistence of HCV.”
BackgroundNatural History of Hepatitis C
Lingala, S., & Ghany, M. G. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.07.003 · Cited by 252
Ando, K., Hiroishi, K., Kaneko, T., Moriyama, T., Muto, Y., Kayagaki, N., Yagita, H., Okumura, K., & Imawari, M. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5283 · Cited by 249 · cited 2×
“Some of the hepatocytes may be damaged via CTL-mediated by standing killing [88].”
BackgroundSerti, E., Chepa-Lotrea, X., Kim, Y. J., Keane, M., Fryzek, N., Liang, T. J., Ghany, M., & Rehermann, B. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.004 · Cited by 245 · cited 1×
“Furthermore, DAA therapy is associated with a normalization of NK cell function [217].”
BackgroundCell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells
Marukian, S., Jones, C. T., Andrus, L., Evans, M. J., Ritola, K. D., Charles, E. D., Rice, C. M., & Dustin, L. B. (2008) · Hepatology · doi:10.1002/hep.22550 · Cited by 240
Nattermann, J., Feldmann, G., Ahlenstiel, G., Langhans, B., Sauerbruch, T., & Spengler, U. (2006) · Gut · doi:10.1136/gut.2005.076463 · Cited by 236 · cited 1×
“An increased expression of inhibitory receptors (CD94/NKG2A) on NK cell in chronic hepatitis C patients [170] coupled with a reduction in the proportion of natural cytotoxicity receptors (NKp30 and NKp46) on NK cells has been noted in HCV patients [171].”
BackgroundJinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Miyagi, T., Suzuki, T., Kanazawa, Y., Hiramatsu, N., & Hayashi, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6072 · Cited by 228 · cited 2×
“An increased expression of inhibitory receptors (CD94/NKG2A) on NK cell in chronic hepatitis C patients [170] coupled with a reduction in the proportion of natural cytotoxicity receptors (NKp30 and NKp46) on NK cells has been noted in HCV patients [171].”
BackgroundRestoration of HCV-specific CD8+ T cell function by interferon-free therapy
Martin, B., Hennecke, N., Lohmann, V., Kayser, A., Neumann-Haefelin, C., Kukolj, G., Böcher, W.-O., & Thimme, R. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.043 · Cited by 223 · cited 1×
“[220] suggested that DAA-mediated removal of HCV antigens could have contributed to a restoration of the proliferative capability of exhausted HCV-specific CD8+ T cells in the majority of patients with a sustained virologic response 12 weeks after cessation of treatment (SVR12).”
BackgroundDe Maria, A., Fogli, M., Mazza, S., Basso, M., Picciotto, A., Costa, P., Congia, S., Mingari, M. C., & Moretta, L. (2007) · European Journal of Immunology · doi:10.1002/eji.200635989 · Cited by 220
Alric, L., Fort, M., Izopet, J., Vinel, J., Charlet, J., Selves, J., Puel, J., Pascal, J., Duffaut, M., & Abbal, M. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352872 · Cited by 220 · cited 2×
“HLA-DRB1*0101 [89,90], HLA DRB1 *0501 [91], and HLA DQB1*0301 [89,92,93] are associated with the spontaneous clearance of HCV.”
BackgroundThe Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors
Romano, K. P., Ali, A., Aydin, C., Soumana, D., Özen, A., Deveau, L. M., Silver, C., Cao, H., Newton, A., Petropoulos, C. J., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002832 · Cited by 219 · cited 1×
“Until recently, available therapeutic options for HCV infection were limited to pegylated interferon (PEG-IFN) and Ribavirin for all genotypes with a sustained virologic response (SVR) achievable in a subset of treated HCV-infected individuals [212].”
BackgroundKanto, T., Inoue, M., Miyatake, H., Sato, A., Sakakibara, M., Yakushijin, T., Oki, C., Itose, I., Hiramatsu, N., Takehara, T., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/425425 · Cited by 217 · cited 3×
“Additionally, HCV-infected DC induces immune tolerance, since they secrete significant amounts of IL-10 [118,180] with a consequential suppression of T cell responses.”
BackgroundMutational escape from CD8+ T cell immunity
Bowen, D. G., & Walker, C. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050808 · Cited by 216
Wu, J., Meng, Z., Jiang, M., Zhang, E., Trippler, M., Broering, R., Bucchi, A., Krux, F., Dittmer, U., Yang, D., et al. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03179.x · Cited by 214 · cited 6×
“HCV-infected hepatocytes secrete type I and III IFN that trigger DC, HSC, and Kupffer cells to produce IL-12, IL-15, and IL-18 to recruit IFN-γ-producing NK cells, whereas type I and III IFN induce LSEC to secrete CXCL10 that recruit activated T cells to the liver [31,60].”
BackgroundInfluentialHepatitis C Virus RNA Replication
Lohmann, V. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_7 · Cited by 213 · cited 1×
“The NS5B and helicase domain of NS3 are regulators of HCV replication, which helps to unwind and stabilize the HCV RNA in a replication complex [41,42].”
BackgroundKeck, Z.-Y., Xia, J., Wang, Y., Wang, W., Krey, T., Prentoe, J., Carlsen, T., Li, A. Y.-J., Patel, A. H., Lemon, S. M., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002653 · Cited by 212 · cited 1×
“It should be effective against the diverse variants of HCV since there is over 30% of nucleotide sequence diversity among the genotypes [226,237].”
BackgroundL-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus
Cormier, E. G., Durso, R. J., Tsamis, F., Boussemart, L., Manix, C., Olson, W. C., Gardner, J. P., & Dragic, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405695101 · Cited by 210 · cited 1×
“Consistent with this, the HCV pseudo virus was shown to bind DC-SIGN expressed on monocyte-derived DCs and was transmitted efficiently when cocultured with the human hepatocellular carcinoma cell line Huh7, a cell line that supports HCV pseudovirus entry and productive infection [116,117].”
BackgroundNattermann, J., Nischalke, H. D., Hofmeister, V., Ahlenstiel, G., Zimmermann, H. W., Leifeld, L., Weiss, E. H., Sauerbruch, T., & Spengler, U. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62267-5 · Cited by 204 · cited 1×
“HCV core 35–44 is a HLA-A2-restricted T cell epitope that increases the stability of HLA-E, a known ligand for the inhibitory receptor CD94/NKG2A on NK cells, which results in a blockade of NK-cell-mediated cytolysis [160].”
BackgroundHepatitis C Virus Core Protein Blocks Interferon Signaling by Interaction with the STAT1 SH2 Domain
Lin, W., Kim, S. S., Yeung, E., Kamegaya, Y., Blackard, J. T., Kim, K. A., Holtzman, M. J., & Chung, R. T. (2006) · Journal of Virology · doi:10.1128/jvi.00459-06 · Cited by 196 · cited 2×
“HCV core protein degrades STAT1, and as such, inhibits the activation of STAT1 [146,147].”
BackgroundTacke, R. S., Lee, H.-C., Goh, C., Courtney, J., Polyak, S. J., Rosen, H. R., & Hahn, Y. S. (2012) · Hepatology · doi:10.1002/hep.24700 · Cited by 195 · cited 3×
“These mechanisms include the production of Nitric Oxide (NO) and reactive oxygen species (ROS) which prevent T cell activation in response to cognate antigen and induce T cell apoptosis.”
BackgroundInfluentialLaw, J. L., Chen, C., Wong, J., Hockman, D. J., Santer, D. M., Frey, S. E., Belshe, R. B., Wakita, T., Bukh, J., Jones, C. T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059776 · Cited by 195 · cited 1×
“[230] demonstrated that an HCV vaccine comprising envelope glycoproteins gpE1/gpE2 derived from a single isolate induced broad cross-neutralizing antibodies against all HCV genotypes with varying efficiency.”
BackgroundImmune evasion versus recovery after acute hepatitis C virus infection from a shared source
Tester, I. A., Smyk‐Pearson, S., Wang, P., Wertheimer, A. M., Yao, E., Lewinsohn, D. M., Tavis, J. E., & Rosen, H. R. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042284 · Cited by 189
Hepatitis B virus molecular biology and pathogenesis
Lamontagne, R. J., Bagga, S., & Bouchard, M. J. (2016) · Hepatoma Research · doi:10.20517/2394-5079.2016.05 · Cited by 186 · cited 1×
“These two glycoproteins interact with CD81 and various other surface proteins such as claudin-1 [1,37,38], occludin, and epidermal growth factor receptor to access the cell [39].”
BackgroundDendritic cells and immune regulation in the liver
Lau, A. H. (2003) · Gut · doi:10.1136/gut.52.2.307 · Cited by 183 · cited 1×
“The expression of TGFβ by hepatic stellate cells may favor the generation of Th2 immune response with production of IL-10 as well as render other liver APCs tolerogenic [131].”
BackgroundHepatitis C virus expression suppresses interferon signaling by degrading STAT1
Lin, W., Choe, W. H., Hiasa, Y., Kamegaya, Y., Blackard, J. T., Schmidt, E. V., & Chung, R. T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.02.006 · Cited by 183 · cited 2×
“HCV core protein degrades STAT1, and as such, inhibits the activation of STAT1 [146,147].”
BackgroundHepatitis C virus mutation affects proteasomal epitope processing
Seifert, U., Liermann, H., Racanelli, V., Halenius, A., Wiese, M., Wedemeyer, H. H., Ruppert, T., Rispeter, K., Henklein, P., Sijts, A. J. A. M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci20985 · Cited by 181
Racial Differences in HLA Class II Associations with Hepatitis C Virus Outcomes
Thio, C. L., Thomas, D. L., Goedert, J. J., Vlahov, D., Nelson, K. E., Hilgartner, M. W., O'Brien, S. J., Karacki, P., Marti, D., Astemborski, J., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/321005 · Cited by 181 · cited 2×
“However, HLA DQB1*0201 [91] and HLA DRB1*0301 [94] are associated with a persistence of HCV. Similar to studies of association between HLA class II alleles and HCV outcomes, some HLA Class I alleles have an effect on the outcome of an HCV infection.”
BackgroundEvidence of Viral Replication in Circulating Dendritic Cells during Hepatitis C Virus Infection
Goutagny, N., Fatmi, A., Ledinghen, V. D., Penin, F., Couzigou, P., Inchauspé, G., & Bain, C. (2003) · The Journal of Infectious Diseases · doi:10.1086/375350 · Cited by 181 · cited 2×
“An infection and replication of HCV in PBDC dysregulates the allostimulatory function and IFN-α production by mDC and pDC respectively in an HCV chronic infection [113].”
BackgroundZeisel, M. B., Felmlee, D. J., & Baumert, T. F. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-27340-7_4 · Cited by 179
Randall, G., Chen, L., Panis, M., Fischer, A. K., Lindenbach, B. D., Sun, J., Heathcote, J., Rice, C. M., Edwards, A. M., & McGilvray, I. D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.043 · Cited by 179
Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape
Meyer-Olson, D., Shoukry, N. H., Brady, K. W., Kim, H., Olson, D. P., Hartman, K., Shintani, A. K., Walker, C. M., & Kalams, S. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040638 · Cited by 177
Lang, K. S., Recher, M., Navarini, A. A., Harris, N. L., Löhning, M., Junt, T., Probst, H. C., Hengartner, H., & Zinkernagel, R. M. (2005) · European Journal of Immunology · doi:10.1002/eji.200425828 · Cited by 176 · cited 1×
“Another phenotypic feature of exhausted CD8+ T cells when compared with memory CD8+ T cells is the lowered expression of IL-7Rα (CD127) and IL-2Rβ (CD122), the receptors for the homeostatic cytokines IL-7 and IL-15, respectively [198,199].”
BackgroundRaghuraman, S., Park, H., Osburn, W. O., Winkelstein, E. R., Edlin, B. R., & Rehermann, B. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir835 · Cited by 176 · cited 1×
“The development of a robust early humoral immune response via neutralizing antibodies in the initial phase of an HCV infection is likely to result in the spontaneous clearance of a viral infection [224,225].”
BackgroundAbnormal Priming of CD4+T Cells by Dendritic Cells Expressing Hepatitis C Virus Core and E1 Proteins
Sarobe, P., Lasarte, J. J., Casares, N., López-Díaz de Cerio, A., Baixeras, E., Labarga, P., García, N., Borrás-Cuesta, F., & Prieto, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.5062-5070.2002 · Cited by 166 · cited 1×
“DC maturation, which in turn, impairs the ability of DC to activate T cells [152].”
BackgroundAnthony, D. D., Yonkers, N. L., Post, A. B., Asaad, R., Heinzel, F. P., Lederman, M. M., Lehmann, P. V., & Valdez, H. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4907 · Cited by 165 · cited 1×
“The HCV NS5 protein impairs the ability of pDCs to produce IFN-α [118,150,151].”
BackgroundLindenbach, B. D. (2013) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-27340-7_8 · Cited by 164 · cited 2×
“HCV also uses fatty acid pathways and very low density lipoprotein (VLDL) production for ssembly and release [43].”
BackgroundAssociation between HLA class II genotype and spontaneous clearance of hepatitis C viraemia
Cramp, M. E., Carucci, P., Underhill, J., Naoumov, N. V., Williams, R., & Donaldson, P. T. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80005-6 · Cited by 161 · cited 2×
“HLA-DRB1*0101 [89,90], HLA DRB1 *0501 [91], and HLA DQB1*0301 [89,92,93] are associated with the spontaneous clearance of HCV.”
BackgroundKaplan, D. E., Sugimoto, K., Newton, K., Valiga, M. E., Ikeda, F., Aytaman, A., Nunes, F. A., Lucey, M. R., Vance, B. A., Vonderheide, R. H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.044 · Cited by 159 · cited 1×
“While CD8+ T cells are the primary effector cells, in the absence of a strong HCV-specific CD4+ T cell response, their ability to keep up with viral replication is lost and a persistent infection develops [83].”
BackgroundHepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges
Bouchard, M. J., & Navas-Martin, S. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.11.014 · Cited by 158 · cited 2×
“Hepatocarcinogenesis and inflammation cause liver damage, which, in turn, affects the functional efficiency of the liver [1].”
BackgroundWard, S. M., Fox, B. C., Brown, P. J., Worthington, J., Fox, S. B., Chapman, R. W., Fleming, K. A., Banham, A. H., & Klenerman, P. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.03.023 · Cited by 155 · cited 1×
“Recent reports also support the premise that Foxp3+ Tregs are elevated during a chronic HCV infection and that the maintenance of these cells may contribute to HCV persistence in some patients [209].”
ResultHerzer, K., Falk, C. S., Encke, J., Eichhorst, S. T., Ulsenheimer, A., Seliger, B., & Krammer, P. H. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8299-8309.2003 · Cited by 150 · cited 1×
“The HCV core protein also increases an expression of MHC class I on infected cells via the enhancement of TAP1 expression, which results in a resistance to the NK cell killing of infected cells [161].”
BackgroundImpairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection
CORADO, J., TORO, F., RIVERA, H., BIANCO, N. E., DEIBIS, L., & DE SANCTIS, J. B. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1997.4581355.x · Cited by 148 · cited 1×
“NK cells constitute about 30–50% of intrahepatic lymphocytes [53].”
BackgroundRutebemberwa, A., Ray, S. C., Astemborski, J., Levine, J., Liu, L., Dowd, K. A., Clute, S., Wang, C., Korman, A., Sette, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.12.8215 · Cited by 131 · cited 1×
“Additionally, high PD-1 levels on HCV specific T cells during an acute infection may determine the viral persistence and progression to a chronic infection [194,197].”
BackgroundWaggoner, S. N., Hall, C. H. T., & Hahn, Y. S. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507268 · Cited by 128 · cited 2×
“HCV core protein interaction with gC1qR on monocyte-derived DC results in an inhibition of TLR-mediated IL-12 production and a reduced IFN-γ production by allogeneic CD4+ T cell with a consequential impairment of Th1 differentiation of CD4+ T cells [153].”
BackgroundWertheimer, A. M., Bakke, A. C., & Rosen, H. R. (2004) · Hepatology · doi:10.1002/hep.20306 · Cited by 127 · cited 1×
“DCs play an important role in initiating adaptive immune response to virus; however, a reduced frequency of mDCs and pDCs is observed during an HCV infection [118,120], and this can be correlated with an impaired capacity of these cells to activate T cells [118].”
BackgroundPlasmacytoid dendritic cells in acute and chronic hepatitis C virus infection†
Ulsenheimer, A., Gerlach, J. T., Jung, M., Gruener, N. H., Wächtler, M., Backmund, M., Santantonio, T. A., Schraut, W., Heeg, M. H. J., Schirren, C. A., et al. (2005) · Hepatology · doi:10.1002/hep.20592 · Cited by 127
Natural killer cells: Primary target for hepatitis C virus immune evasion strategies?
Golden‐Mason, L., & Rosen, H. R. (2006) · Liver Transplantation · doi:10.1002/lt.20708 · Cited by 119
Yergin, C. G., Roggerson, K. M., Lee, H., Golden‐Mason, L., Rosen, H. R., & Hahn, Y. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501881 · Cited by 112 · cited 1×
“Importantly, this suppression of NK cell–derived IFN-γ production was mediated by CD33+CD11blowHLA-DRlow MDSCs via an arginase-1–dependent inhibition of the mammalian target of rapamycin activation which results in a reduced protein translation [174].”
BackgroundLucas, M., Gadola, S. D., Meier, U., Young, N. T., Harcourt, G., Karadimitris, A., Coumi, N., Brown, D., Dusheiko, G. M., Cerundolo, V., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2251-2257.2003 · Cited by 112 · cited 1×
“While one report indicates an increase in NKT cell frequency in the liver of patients with a chronic HCV infection [62], another has observed a decrease [63].”
BackgroundLauer, G. M., Lucas, M., Timm, J., Ouchi, K., Kim, A. Y., Day, C. L., Wiesch, J. S. Z., Paranhos‐Baccalà, G., Sheridan, I., Casson, D. R., et al. (2005) · Journal of Virology · doi:10.1128/jvi.79.20.12979-12988.2005 · Cited by 110 · cited 1×
“A sustained vigorous HCV-specific CTL response is associated with the resolution of an acute HCV infection; however, suboptimal performing CTL correlates with viral persistence [81,82].”
BackgroundKonan, K. V., Giddings, T. H., Ikeda, M., Li, K., Lemon, S. M., & Kirkegaard, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7843-7855.2003 · Cited by 108 · cited 1×
“The HCV NS4A/B protein can block HLA class I expressions on surfaces of infected cells by inhibiting the endoplasmic reticulum–Golgi traffic [162], which results in an impaired recognition of HCV-infected hepatocytes by HCV-specific CD8+ T cells.”
BackgroundGiugliano, S., Kriss, M., Golden-Mason, L., Dobrinskikh, E., Stone, A. E. L., Soto-Gutierrez, A., Mitchell, A., Khetani, S. R., Yamane, D., Stoddard, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.10.040 · Cited by 108 · cited 6×
“HCV-infected hepatocytes secrete type I and III IFN that trigger DC, HSC, and Kupffer cells to produce IL-12, IL-15, and IL-18 to recruit IFN-γ-producing NK cells, whereas type I and III IFN induce LSEC to secrete CXCL10 that recruit activated T cells to the liver [31,60].”
InfluentialKanto, T., & Hayashi, N. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1530 · Cited by 105 · cited 3×
“Resident cells in the liver such as LSEC, Kupffer cells, and hepatic stellate cells promote a tolerogenic microenvironment in the liver by inducing tolerance to infiltrating effector CD4 T cells and CD8 T cells [86].”
BackgroundIs hepatitis C virus infection of dendritic cells a mechanism facilitating viral persistence?
Pachiadakis, I., Pollara, G., Chain, B., & Naoumov, N. V. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70114-6 · Cited by 105 · cited 1×
“In addition to infecting hepatocytes, HCV has been reported to infect dendritic cells (DCs) [16,17], B cells [18,19], and peripheral blood mononuclear cells [20,21].”
BackgroundZavaglia, C., Martinetti, M., Silini, E. M., Bottelli, R., Daielli, C., Asti, M., Airoldi, A., Salvaneschi, L., Mondelli, M. U., & Ideo, G. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80195-5 · Cited by 103
Saito, K., Meyer, K., Warner, R., Basu, A., Ray, R. B., & Ray, R. (2006) · Journal of Virology · doi:10.1128/jvi.80.9.4372-4379.2006 · Cited by 103 · cited 1×
“Some reports show the HCV core protein inducing Fas-mediated apoptosis [164,165], and others reports emphasize their role in inhibiting TNF-α-mediated apoptosis via its upregulation of cellular FLICE (FADD-like interleukin-1β converting enzyme) like inhibitory protein (cFLIP) [166].”
BackgroundRadziewicz, H., Ibegbu, C., Hon, H., Osborn, M. K., Obideen, K. M., Wehbi, M. A., Freeman, G. J., Lennox, J. L., Workowski, K., Hanson, H. L., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01075-08 · Cited by 102 · cited 1×
“Impaired HCV-specific CD8+ T cells were also observed to undergo massive apoptosis in the liver during the chronic phase [189].”
BackgroundKeck, Z., Li, S. H., Xia, J., von Hahn, T., Balfe, P., McKeating, J. A., Witteveldt, J., Patel, A. H., Alter, H. J., Rice, C. M., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00248-09 · Cited by 101 · cited 1×
“A mutation affecting the binding site of E2 on CD81 could result in the development of resistance to broad neutralizing antibodies in an HCV infection [68,73].”
BackgroundRole of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis
Ahmad, A., & Alvarez, F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304197 · Cited by 100 · cited 8×
“Furthermore, the HCV core-mediated suppression of IL-2 production could contribute to an impaired differentiation of the central memory HCV-specific CD8 T cells into effector HCV-specific CD8+ T cells [86,155].”
BackgroundInfluentialHarizi, H. (2013) · Cellular and Molecular Immunology · doi:10.1038/cmi.2013.1 · Cited by 99 · cited 1×
“The presence of adequate NK cell response and matured DCs are critical for inducing an effective HCV-specific adaptive response [56], as a reciprocating activating crosstalk between DCs and NK cells is vital in driving the antiviral innate immune response [168].”
BackgroundRigopoulou, E. I., Abbott, W. G. H., Haigh, P., & Naoumov, N. V. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.06.003 · Cited by 98 · cited 1×
“An increased secretion of IL-10 has been observed for various chronic viral infections, including HCV [202,203].”
BackgroundDeignan, T., Curry, M. P., Doherty, D. G., Golden‐Mason, L., Volkov, Y., Norris, S., Nolan, N. P., Traynor, O., McEntee, G., Hegarty, J. E., et al. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00072-7 · Cited by 98 · cited 1×
“While one report indicates an increase in NKT cell frequency in the liver of patients with a chronic HCV infection [62], another has observed a decrease [63].”
BackgroundDendritic cell susceptibility to hepatitis C virus genotype 1 infection
Navas, M. C., Fuchs, A., Schvoerer, É., Bohbot, A., Aubertin, A.-M., & Stoll‐Keller, F. (2002) · Journal of Medical Virology · doi:10.1002/jmv.2204 · Cited by 98
Nattermann, J., Zimmermann, H. W., Iwan, A., von Lilienfeld‐Toal, M., Leifeld, L., Nischalke, H. D., Langhans, B., Sauerbruch, T., & Spengler, U. (2006) · Hepatology · doi:10.1002/hep.21350 · Cited by 93
Ha, S., West, E. E., Araki, K., Smith, K. A., & Ahmed, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00638.x · Cited by 91 · cited 1×
“Due to the inability of the immune system to control the viral load during chronic infections, significant levels of viral loads correlate with a persistent exposure of T cells to HCV, which render T cells exhausted [182].”
BackgroundEbihara, T., Shingai, M., Matsumoto, M., Wakita, T., & Seya, T. (2008) · Hepatology · doi:10.1002/hep.22337 · Cited by 87 · cited 1×
“Dysfunctional DC in HCV infection are unable to induce cytokine-dependent NK cell maturation and T cell priming [156,179].”
BackgroundSantín, I., Moore, F., Grieco, F. A., Marchetti, P., Brancolini, C., & Eizirik, D. L. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.158 · Cited by 86
The Role of Regulatory T Cells in Chronic and Acute Viral Infections
Keynan, Y., Card, C. M., McLaren, P. J., Dawood, M. R., Kasper, K., & Fowke, K. R. (2008) · Clinical Infectious Diseases · doi:10.1086/529379 · Cited by 85 · cited 1×
“Though they may attenuate HCV-specific T cell responses in the liver, their presence may also reduce the risks of hepatic injury as incurred by the presence of a sustained CTL response [211].”
BackgroundKaplan, D. E., Ikeda, F., Li, Y., Nakamoto, N., Ganesan, S., Valiga, M. E., Nunes, F. A., Reddy, K. R., & Chang, K. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.01.030 · Cited by 83 · cited 1×
“While allowing viral persistence, the presence of IL-10 in the liver could also be beneficial in regulating constantly activated T cells that could aggravate immunopathology and cause fibrosis of the liver [206].”
BackgroundHepatic NKT cells: friend or foe?
Swain, M. G. (2008) · Clinical Science · doi:10.1042/cs20070328 · Cited by 81 · cited 1×
“Though its precise role in a chronic infection is yet unclear, there are indications that NKT cells may influence the balance of TH1 versus TH2 responses to an HCV infection [61].”
BackgroundMuratori, L., Gibellini, D., Lenzi, M., Cataleta, M., Muratori, P., Morelli, M. C., & Bianchi, F. B. (1996) · Blood · doi:10.1182/blood.v88.7.2768.bloodjournal8872768 · Cited by 81 · cited 1×
“In addition to infecting hepatocytes, HCV has been reported to infect dendritic cells (DCs) [16,17], B cells [18,19], and peripheral blood mononuclear cells [20,21].”
BackgroundPuig, M., Mihalik, K., Tilton, J. C., Williams, O., Merchlinsky, M. J., Connors, M., Feinstone, S. M., & Major, M. E. (2006) · Hepatology · doi:10.1002/hep.21319 · Cited by 80 · cited 1×
“HCV mutations located in NS3 and NS5 are targeted by CD4+ T cells, and these escape mutants to HCV-specific CD4+ T cell responses contribute to immune evasion [137].”
BackgroundIsraelow, B., Narbus, C. M., Sourisseau, M., & Evans, M. J. (2014) · Hepatology · doi:10.1002/hep.27227 · Cited by 79 · cited 1×
“Thus, a defect in type I and III IFN signaling renders hepatocytes highly susceptible to HCV [31,50].”
BackgroundHepatitis C Vaccines, Antibodies, and T Cells
Shoukry, N. H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01480 · Cited by 79 · cited 1×
“However, this protective immunity is not absolute since it cannot prevent reinfection by HCV variants that did not induce the preexisting memory T cells [227,229].”
BackgroundInnate and Adaptive Immune Responses in Chronic HCV Infection
Dustin, L. B. (2015) · Current Drug Targets · doi:10.2174/1389450116666150825110532 · Cited by 78 · cited 5×
“Although the expression of coinhibitory molecules on activated T cells is protective, an overexpression of coinhibitory receptors in the setting of a low expression of CD127 on HCV-specific CD4+ T cells is associated with a persistent HCV infection, in which, the loss of CD4+ T cell negatively impact on the functional…”
BackgroundInfluentialE2 of Hepatitis C Virus Inhibits Apoptosis
Lee, S. H., Kim, Y. K., Kim, C. S., Seol, S. K., Kim, J., Cho, S., Song, Y.-L., Bartenschlager, R. F. W., & Jang, S. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8226 · Cited by 74
Keck, Z., Girard-Blanc, C., Wang, W., Lau, P., Zuiani, A., Rey, F. A., Krey, T., Diamond, M., & Foung, S. K. H. (2016) · Journal of Virology · doi:10.1128/jvi.02458-15 · Cited by 73 · cited 1×
“occurring in the hypervariable region 1 of E2 along with the potential of HVR 1 to interfere with the binding of antibodies to E2 [233], (4) the cell to cell transmission of HCV constituting a considerable hindrance to developing B-cell-based HCV vaccines that induce broad cross-neutralizing antibodies since HCV could…”
BackgroundHepatitis C virus infects T cells and affects interferon-γ signaling in T cell lines
Kondo, Y., Sung, V. M.-H., Machida, K., Liu, M., & Lai, M. M. C. (2006) · Virology · doi:10.1016/j.virol.2006.11.009 · Cited by 71
Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?
Walker, C. M., & Grakoui, A. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.06.010 · Cited by 71 · cited 1×
“(1) An HCV genomic variability with seven distinct genotypes with more than 65 subtypes which differ in nucleotide sequence, (2) a high error prone mutation rate of HCV with the capability to escape selection pressure by neutralizing antibodies and CD8+ T cells [232], (3) a high mutation rate”
BackgroundSignatures of Protective Memory Immune Responses During Hepatitis C Virus Reinfection
Abdel-Hakeem, M. S., Bédard, N., Murphy, D. G., Bruneau, J., & Shoukry, N. H. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.07.005 · Cited by 69 · cited 1×
“However, this protective immunity is not absolute since it cannot prevent reinfection by HCV variants that did not induce the preexisting memory T cells [227,229].”
BackgroundCurrent Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony
Jamma, S., Hussain, G., & Lau, D. (2010) · Current Hepatology Reports · doi:10.1007/s11901-010-0060-4 · Cited by 69 · cited 1×
“Some of these infections are coinfections with different viruses such as HIV, which furthers the complication [6,7].”
BackgroundMurakami, H., Akbar, S. M. F., Matsui, H., Horiike, N., & Onji, M. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02550.x · Cited by 66
Hepatitis C virus vaccine candidates inducing protective neutralizing antibodies
Fauvelle, C., Colpitts, C. C., Keck, Z., Pierce, B. G., Foung, S. K. H., & Baumert, T. F. (2016) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1194759 · Cited by 64 · cited 1×
“It should be effective against the diverse variants of HCV since there is over 30% of nucleotide sequence diversity among the genotypes [226,237].”
BackgroundKanto, T., Inoue, M., Miyazaki, M., Itose, I., Miyatake, H., Sakakibara, M., Yakushijin, T., Kaimori, A., Oki, C., Hiramatsu, N., et al. (2005) · Intervirology · doi:10.1159/000087264 · Cited by 59 · cited 12×
“While allowing viral persistence, the presence of IL-10 in the liver could also be beneficial in regulating constantly activated T cells that could aggravate immunopathology and cause fibrosis of the liver [206].”
BackgroundInfluentialZimmermann, M., Flechsig, C., Monica, N. L., Tripodi, M., Adler, G., & Dikopoulos, N. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.008 · Cited by 58 · cited 2×
“Dysfunctional DC in HCV infection are unable to induce cytokine-dependent NK cell maturation and T cell priming [156,179].”
BackgroundHenderson, E. A., Louie, T., Ramotar, K., Ledgerwood, D., Hope, K., & Kennedy, A. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501756 · Cited by 57 · cited 1×
“Likewise, an HCV-associated DC dysfunction could be attributed to the induction of pDC apoptosis, impaired DC trafficking due to a nonresponse to CCL21, and a reduced activation of DC via the downregulation of pattern recognition receptors [31,177,178].”
BackgroundAccapezzato, D., Francavilla, V., Rawson, P. M., Cerino, A., Cividini, A., Mondelli, M. U., & Barnaba, V. (2004) · European Journal of Immunology · doi:10.1002/eji.200324540 · Cited by 57
Wang, L., Cao, D., Wang, L., Zhao, J., Nguyen, L. N., Dang, X., Ji, Y., Wu, X. Y., Morrison, Z. D., Xie, Q. R., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0052-z · Cited by 57 · cited 1×
“Importantly, this M-MDSC expansion is mediated by a downregulation of the miR-124 expression [112].”
BackgroundBonavita, M. S., Franco, A., Paroli, M., Santilio, I., Benvenuto, R., Petrillo, G. D., Levrero, M., Perrone, A., Balsano, C., & Barnaba, V. (1993) · PubMed · Cited by 56
Ren, J. P., Zhao, J., Dai, J., Griffin, J. W. D., Wang, L., Wu, X. Y., Morrison, Z. D., Li, G. Y., Gazzar, M. E., Ning, S., et al. (2016) · Immunology · doi:10.1111/imm.12616 · Cited by 55 · cited 1×
“Another study has reported an expansion of M-MDSCs (CD14+CD33+CD11b+HLA-DR-/low) in the peripheral blood of chronic HCV patients [110].”
BackgroundHepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response
Bode, J. G., Brenndörfer, E. D., & Häussinger, D. (2008) · Biological Chemistry · doi:10.1515/bc.2008.147 · Cited by 54 · cited 8×
“Cells 2019, 8, 376 4 of 27 4 to increase the efficiency f translation and Cyclop ilin A, which interacts with NS5A and NS5B to increase HCV replication [14].”
BackgroundInfluentialZeng, Q., Yang, B., Sun, H., Feng, G., Jin, L., Zou, Z., Zhang, Z., Zhang, J., & Wang, F. (2014) · Molecules and Cells · doi:10.14348/molcells.2014.2282 · Cited by 53
Alao, H., Cam, M., Keembiyehetty, C. N., Zhang, F., Serti, E., Suarez, D., Park, H., Fourie, N. H., Wright, E. C., Henderson, W. A., et al. (2018) · Hepatology · doi:10.1002/hep.29921 · Cited by 50 · cited 1×
“[219] demonstrated that baseline ISGs (Interferon stimulated genes) were upregulated in DAA-cured HCV patients, suggesting a role for innate immunity in the clearance of HCV during DAA therapy.”
BackgroundSubversion of innate host antiviral strategies by the hepatitis C virus
Bode, J. G., Brenndörfer, E. D., & Häussinger, D. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.033 · Cited by 48 · cited 8×
“It is important to note that, during HCV infection, the levels of IFNs and ISGs are always upregulated in the cell.”
BackgroundInfluentialExtrahepatic Manifestations of Hepatitis C Infection: Navigating CHASM
Sherman, A. C., & Sherman, K. E. (2015) · Current HIV/AIDS Reports · doi:10.1007/s11904-015-0274-8 · Cited by 47 · cited 1×
“Extrahepatic manifestations of a chronic HCV infection include mixed cryoglobulinemia, membranoproliferative glomerulonephritis, lichen planus, vitiligo, keratoconjunctivitis sicca, and lymphoma [34,35].”
BackgroundIntrahepatic status of regulatory T cells in autoimmune liver diseases and chronic viral hepatitis
Sakaki, M., Hiroishi, K., Baba, T., Ito, T., Hirayama, Y., Saito, K., Tonoike, T., Kushima, M., & Imawari, M. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00284.x · Cited by 44 · cited 1×
“In chronic HCV-infected livers, Foxp3+ Treg cells as well as IL-10 secreting virus-specific CCR7- CD8+ TR cells have been identified [202,210].”
BackgroundImpact of HCV genetic differences on pathobiology of disease
Ripoli, M. C., & Pazienza, V. (2011) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.11.94 · Cited by 43 · cited 1×
“For example, the Type 1 genotype is more aggressive and more directly linked to HCC and cirrhosis, and Type 3 is associated with steatosis and fibrosis [23,24].”
BackgroundPeripheral B Cells May Serve as a Reservoir for Persistent Hepatitis C Virus Infection
Ito, M., Masumi, A., Mochida, K., Kukihara, H., Moriishi, K., Matsuura, Y., Yamaguchi, K., & Mizuochi, T. (2010) · Journal of Innate Immunity · doi:10.1159/000317690 · Cited by 43 · cited 1×
“HCV infection and replication in CD4+ T cells result in a reduced proliferative capacity, an enhanced Fas-mediated apoptosis, and the suppression of IFN secretion [87,123], whereas the infection of B cells via the interaction with CD21, CD19, and CD81 complexes [124] can result in malignant lymphoma, since peripheral…”
BackgroundImmune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence
Hiroishi, K., Ito, T., & Imawari, M. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05475.x · Cited by 43 · cited 6×
“and IL-2, which enhance the antigen presenting capabilities of DC and the proliferation of HCV-specific CD8+ T cells respectively [45,67].”
BackgroundInfluentialde Araujo, A. C., Astrakhantseva, I. V., Fields, H. A., & Kamili, S. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01064-10 · Cited by 42 · cited 1×
“demonstrated that a chronic HCV infection was associated with higher levels of anti-HCV IgG response than in an acute HCV infection [71].”
BackgroundDirect effects of hepatitis C virus on the lymphoid cells
Kondo, Y., & Shimosegawa, T. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i44.7889 · Cited by 40 · cited 1×
“The replication of HCV in T cells is associated with a reduction in IFN-γ production due to the inhibition of STAT1 activation as well as an enhanced susceptibility to Fas signaling [127].”
BackgroundBurchill, M. A., Roby, J. A., Crochet, N., Wind‐Rotolo, M., Stone, A. E. L., Edwards, M. G., Dran, R. J., Kriss, M. S., Gale, M., & Rosen, H. R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186213 · Cited by 39 · cited 1×
“The reduced secretion of these chemokines along with the normalization of NK cell function correlates with a reversal of dysregulated innate immunity leading to reestablishing homeostasis of the innate immune system [218].”
BackgroundSong, X., Yao, Z., Yang, J., Zhang, Z., Deng, Y., Li, M., Ma, C., Yang, L., Gao, X. M., Li, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9304 · Cited by 33 · cited 1×
“Moreover, the interaction of HCV core with gC1qR on macrophages induces the expression of A20, a negative regulator in macrophages with a consequential reduction in the secretion of IL-1 and IL-6 [157].”
BackgroundMissale, G., Cariani, E., & Ferrari, C. I. (2004) · Digestive and Liver Disease · doi:10.1016/j.dld.2004.07.004 · Cited by 32
Semmo, N., Krashias, G., Willberg, C. B., & Klenerman, P. (2007) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2007.00842.x · Cited by 29 · cited 1×
“In chronic HCV infection, CD4+ T cells have a limited functionality due to an impaired proliferative capacity as a consequence of the HCV core-mediated suppression of IL-2 secretion [77].”
BackgroundCallendret, B., Eccleston, H. B., Satterfield, W. C., Capone, S., Folgori, A., Cortese, R., Nicosia, A., & Walker, C. M. (2015) · Hepatology · doi:10.1002/hep.28309 · Cited by 28
Hepatitis C Virus Infection and Vaccine Development
Guo, X., Jin-yi, Z., & Li, J. (2018) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2018.02.003 · Cited by 26 · cited 8×
“Exhausted HCV-specific CD8+ T cell expresses PD-1, 2B4, TIM-3, CTLA4, or CD160 with a reduced expression of CD127 [79].”
BackgroundInfluentialImmunopathogenesis of Hepatitis C Virus Infection
Kaplan, D. E. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.07.004 · Cited by 21 · cited 16×
“Likewise, an HCV-associated DC dysfunction could be attributed to the induction of pDC apoptosis, impaired DC trafficking due to a nonresponse to CCL21, and a reduced activation of DC via the downregulation of pattern recognition receptors [31,177,178].”
BackgroundInfluentialImmune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing
van der Ree, M. H., Stelma, F., Willemse, S. B., Brown, A., Swadling, L., van der Valk, M., Sinnige, M. J., van Nuenen, A. C., de Vree, J. M. L., Klenerman, P., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.08.016 · Cited by 19
Wang, Y., Li, J., Wang, X., Ye, L., Zhou, Y., & Ho, W. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12040 · Cited by 18 · cited 5×
“HSC and LSEC are nonimmune cells resident in the liver that exhibit antiviral effects in response to an HCV infection.”
BackgroundInfluentialPreferential association of hepatitis C virus with CD19+ B cells is mediated by complement system
Wang, R. Y., Baré, P., Giorgi, V. D., Matsuura, K., Salam, K. A., Grandinetti, T., Schechterly, C. A., & Alter, H. J. (2016) · Hepatology · doi:10.1002/hep.28842 · Cited by 18 · cited 1×
“HCV infection and replication in CD4+ T cells result in a reduced proliferative capacity, an enhanced Fas-mediated apoptosis, and the suppression of IFN secretion [87,123], whereas the infection of B cells via the interaction with CD21, CD19, and CD81 complexes [124] can result in malignant lymphoma, since peripheral…”
BackgroundNeukam, K., Nattermann, J., Rallón, N. I., Rivero, A., Carúz, A., Macías, J., Vogel, M., Benito, J. M., Camacho, Á., Mira, J. A., et al. (2011) · HIV Medicine · doi:10.1111/j.1468-1293.2011.00912.x · Cited by 18 · cited 1×
“The IL28B genotype CC was found to be linked with more infections from genotype 3 than genotype 1 or 4 in HIV-coinfected patients [26].”
BackgroundDendritic Cells in HIV-1 and HCV Infection: Can They Help Win the Battle?
Sehgal, M., Khan, Z. K., Talal, A. H., & Jain, P. (2013) · Virology Research and Treatment · doi:10.4137/vrt.s11046 · Cited by 16 · cited 1×
“In addition to infecting hepatocytes, HCV has been reported to infect dendritic cells (DCs) [16,17], B cells [18,19], and peripheral blood mononuclear cells [20,21].”
BackgroundSelf-citationEarly Prostate Cancer: Hedonic Prices Model of Provider–Patient Interactions and Decisions
Jani, A. B., & Hellmän, S. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.07.2349 · Cited by 9 · cited 1×
“Likewise, an interaction between an HCV core and DC results in a skew in the T cell response to IL-4 and IL-10 producing T cell due to the HCV core-mediated inhibition of IL-12 production [78].”
Background
Metadata
- Authors
- Chigbu, D., Loonawat, R., Sehgal, M., Patel, D., & Jain, P.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-04-25
- Volume
- 8
- Issue
- 4
- Pages
- 376
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W2941957850
- Cited by
- 169
- References
- 202
- FWCI
- 10.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.